Search results
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 9 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi
Investing.com· 1 day agoThe deal, which includes upfront and milestone payments of around $1.3 billion, half of which is...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
GuruFocus.com via Yahoo Finance· 4 hours agoThe partnership with Sanofi allows Novavax Inc (NASDAQ:NVAX) to leverage Sanofi's extensive global vaccine business expertise, potentially leading to hundreds ...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 3 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 3 days agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 3 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 3 days agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 20 hours agoUltimately, it depends on when you got your last dose. In fall, an updated COVID vaccine was...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 3 days agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...